Overview

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study evaluated the safety and efficacy of ranibizumab on retinal edema and visual acuity in patients with diabetic macular edema with center involvement.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Ranibizumab